期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

临床药师参与连续静—静脉血液滤过(CVVH)时万古霉素给药剂量方案设计 被引量：1

原文传递
导出
摘要 万古霉素是目前治疗耐甲氧西林葡萄球菌等感染的首选抗生素,但其具有潜在的耳、肾毒性,尤其对于合并肾功能不全且在ICU接受连续静—静脉血液滤过（CVVH）治疗的患者,合理使用万古霉素是临床药师在临床实践中的关注点。我国《万古霉素临床应用剂量专家共识（2012版）》（下称专家共识）[1]推荐对于接受置换液流速为1.5L/h的血液透析的重症感染患者,负荷剂量为25~30mg/kg（按实际体质量算）.
作者 郭茵 李泳桃
机构地区 广州市番禺区中心医院
出处 《临床合理用药杂志》 2016年第8期82-83,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 连续静—静脉血液滤过 万古霉素 用药剂量
分类号 R459.5 [医药卫生—治疗学]
  • 相关文献

参考文献5

二级参考文献22

  • 1Kuang D, Verbine A, Ronco C, et al. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy [ J ]. Clin Nephrol, 2007,67 (5) :267 -284.
  • 2Vincent HT, Lomacstro BM. Drug dosing in patients undergoing continuous renal replacement therapy[ J]. NY State J Healthsyst Pharmacist,2001,20 ( 1 ) : 10 - 14.
  • 3Pinder M, Bellomo R, Lipman J, et al. Pharmacological principles of antibiotic prescription in the critically ill [ J ]. Anaesth Intensive Care,2002,30(2) : 134 - 144.
  • 4Isla A, Gascon AR, Maynar J, et al. Cefepime and continuous renal replacement therapy (CRRT) : in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients[J]. Clin Ther,2005,27 (5) :599 - 608.
  • 5Rebecca S, Malone, Douglas N, et al. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically Ⅲ patients[ J]. Antimicrob Agents Chemother,2001,45 ( 11 ) : 3148 -3155.
  • 6Douglas N,Fish ,Teitelbaum I, et al. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically Ⅲ patients[ J]. Antimicrob Agents Chemother,2005,49 (6) :2421 - 2428.
  • 7Rebecca S, Malone, Douglas N, et al. Pharmacokinetics of Levo- floxacln and Ciprofloxacin during Continuous Renal Replacement Therapy in Critically Ⅲ Patients[J]. Antimicrob Agents Chemother,2001,45 ( 10 ) : 2949 - 2954.
  • 8Fuhrmann V, Schenk P, Jaeger W, et al. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration [ J ]. J Antimicrob Chemother,2007,60 (5) : 1085 - 1090.
  • 9Meyer B, Thalhammer F, Linezolid and continuous venovenous hemofiltration [ J]. Clin Infect Dis,2006,42( 3 ) :435 - 436.
  • 10Arzuaga A,Maynar J, Alicia R, et al. Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive Care unit patients during continuous venovenous hemofiltration [ J]. J Clin Pharmacol,2005,45 (2) : 168 - 176.

共引文献308

同被引文献9

引证文献1

二级引证文献4

临床合理用药杂志
2016年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部